M&A Roundtable and 2024 Predictions

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:

• Sabina Ouimet-Storrs, Principal at GHO Capital Partners
• James West, Managing Director at Lincoln International
• Derek Hennecke, investor and board member in biopharma and cell therapy manufacturing

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his guests, covering:

• The year of the failed process in 2023…
• Which sub-segments of the pharma services ecosystem are hot right now?
• A myriad of buys and builds, carve-outs, and platform deals
• An optimistic outlook for the year ahead… despite some significant market headwinds

Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.